IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months
Purpose There is a lack of adjudicated and prospectively randomized published outcomes on the use of drug‐coated balloons (DCB) to treat dysfunctional arteriovenous fistula in Asian patients. This post hoc subgroup analysis of 112 Japanese participants from the global IN.PACT AV Access trial reports...
Gespeichert in:
| Veröffentlicht in: | Therapeutic apheresis and dialysis 2023-08, Vol.27 (4), p.682-693 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 693 |
|---|---|
| container_issue | 4 |
| container_start_page | 682 |
| container_title | Therapeutic apheresis and dialysis |
| container_volume | 27 |
| creator | Haruguchi, Hiroaki Suemitsu, Kotaro Isogai, Naoko Murakami, Masaaki Fujihara, Masahiko Iwadoh, Kazuhiro Menk, Jeremiah Ookubo, Hiroko Ogawa, Tomonari |
| description | Purpose
There is a lack of adjudicated and prospectively randomized published outcomes on the use of drug‐coated balloons (DCB) to treat dysfunctional arteriovenous fistula in Asian patients. This post hoc subgroup analysis of 112 Japanese participants from the global IN.PACT AV Access trial reports outcomes through 12 months.
Materials and Methods
Participants were treated with DCB (n = 58) or standard non‐coated percutaneous transluminal angioplasty (PTA) balloons (n = 54). Outcomes included target lesion primary patency (TLPP), access circuit primary patency, and safety.
Results
Through 6 months, TLPP was 86.0% (49/57) in the DCB group and 49.1% (26/53) in the PTA group (p |
| doi_str_mv | 10.1111/1744-9987.13966 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2761986505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2761986505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4746-a49442413efe73cbba769051a3e71bbdb66a0cfe2a41fa437e2351ea60a92de3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQQC0EoqUwsyGPLGnt2LFrtqjio6hAh4rVcpwLDUrqYidCZWLlb_JLaGnpipezTu_e8BA6p6RP129AJeeRUkPZp0wJcYC6-83h_i9VB52E8EpIHHPGjlGHCUGEGLIuehg_9qfpaIbTZ2yshRCwN4vc1eUH5Ljxpamu8L1ZmgW2bu58g13bWFdDwM3cu_Zljmn8_flVu0UzD6foqDBVgLPd7KHZzfVsdBdNnm7Ho3QSWS65iAxXnMecMihAMptlRgpFEmoYSJpleSaEIbaA2HBaGM4kxCyhYAQxKs6B9dDlVrv07q2F0Oi6DBaqyizAtUHHUlA1FAlJ1uhgi1rvQvBQ6KUva-NXmhK9Sag3kfQmmP5NuL642MnbrIZ8z_81WwPJFngvK1j959OzdLoV_wCC6Hsq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2761986505</pqid></control><display><type>article</type><title>IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Haruguchi, Hiroaki ; Suemitsu, Kotaro ; Isogai, Naoko ; Murakami, Masaaki ; Fujihara, Masahiko ; Iwadoh, Kazuhiro ; Menk, Jeremiah ; Ookubo, Hiroko ; Ogawa, Tomonari</creator><creatorcontrib>Haruguchi, Hiroaki ; Suemitsu, Kotaro ; Isogai, Naoko ; Murakami, Masaaki ; Fujihara, Masahiko ; Iwadoh, Kazuhiro ; Menk, Jeremiah ; Ookubo, Hiroko ; Ogawa, Tomonari ; IN.PACT AV Access Investigators ; the IN.PACT AV Access Investigators</creatorcontrib><description>Purpose
There is a lack of adjudicated and prospectively randomized published outcomes on the use of drug‐coated balloons (DCB) to treat dysfunctional arteriovenous fistula in Asian patients. This post hoc subgroup analysis of 112 Japanese participants from the global IN.PACT AV Access trial reports outcomes through 12 months.
Materials and Methods
Participants were treated with DCB (n = 58) or standard non‐coated percutaneous transluminal angioplasty (PTA) balloons (n = 54). Outcomes included target lesion primary patency (TLPP), access circuit primary patency, and safety.
Results
Through 6 months, TLPP was 86.0% (49/57) in the DCB group and 49.1% (26/53) in the PTA group (p < 0.001). Through 12 months, TLPP was 67.3% (37/55) in the DCB group and 43.4% (23/53) in the PTA group (p = 0.013).
Conclusion
In this post hoc analysis of Japanese participants from the IN.PACT AV Access trial, participants treated with DCB had higher TLPP through 6 and 12 months compared with PTA.</description><identifier>ISSN: 1744-9979</identifier><identifier>EISSN: 1744-9987</identifier><identifier>DOI: 10.1111/1744-9987.13966</identifier><identifier>PMID: 36606683</identifier><language>eng</language><publisher>Kyoto, Japan: John Wiley & Sons Australia, Ltd</publisher><subject>balloon angioplasty ; dialysis access ; drug‐coated balloon ; hemodialysis fistula ; randomized trial ; renal failure</subject><ispartof>Therapeutic apheresis and dialysis, 2023-08, Vol.27 (4), p.682-693</ispartof><rights>2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis and Japanese Society for Apheresis.</rights><rights>2023 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis and Japanese Society for Apheresis.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4746-a49442413efe73cbba769051a3e71bbdb66a0cfe2a41fa437e2351ea60a92de3</citedby><cites>FETCH-LOGICAL-c4746-a49442413efe73cbba769051a3e71bbdb66a0cfe2a41fa437e2351ea60a92de3</cites><orcidid>0000-0002-7001-9220 ; 0000-0001-5713-987X ; 0000-0002-2294-194X ; 0000-0002-4251-5315 ; 0000-0002-5184-6335 ; 0000-0001-5000-5203 ; 0000-0003-1670-7740 ; 0000-0003-3332-2527</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1744-9987.13966$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1744-9987.13966$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36606683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haruguchi, Hiroaki</creatorcontrib><creatorcontrib>Suemitsu, Kotaro</creatorcontrib><creatorcontrib>Isogai, Naoko</creatorcontrib><creatorcontrib>Murakami, Masaaki</creatorcontrib><creatorcontrib>Fujihara, Masahiko</creatorcontrib><creatorcontrib>Iwadoh, Kazuhiro</creatorcontrib><creatorcontrib>Menk, Jeremiah</creatorcontrib><creatorcontrib>Ookubo, Hiroko</creatorcontrib><creatorcontrib>Ogawa, Tomonari</creatorcontrib><creatorcontrib>IN.PACT AV Access Investigators</creatorcontrib><creatorcontrib>the IN.PACT AV Access Investigators</creatorcontrib><title>IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months</title><title>Therapeutic apheresis and dialysis</title><addtitle>Ther Apher Dial</addtitle><description>Purpose
There is a lack of adjudicated and prospectively randomized published outcomes on the use of drug‐coated balloons (DCB) to treat dysfunctional arteriovenous fistula in Asian patients. This post hoc subgroup analysis of 112 Japanese participants from the global IN.PACT AV Access trial reports outcomes through 12 months.
Materials and Methods
Participants were treated with DCB (n = 58) or standard non‐coated percutaneous transluminal angioplasty (PTA) balloons (n = 54). Outcomes included target lesion primary patency (TLPP), access circuit primary patency, and safety.
Results
Through 6 months, TLPP was 86.0% (49/57) in the DCB group and 49.1% (26/53) in the PTA group (p < 0.001). Through 12 months, TLPP was 67.3% (37/55) in the DCB group and 43.4% (23/53) in the PTA group (p = 0.013).
Conclusion
In this post hoc analysis of Japanese participants from the IN.PACT AV Access trial, participants treated with DCB had higher TLPP through 6 and 12 months compared with PTA.</description><subject>balloon angioplasty</subject><subject>dialysis access</subject><subject>drug‐coated balloon</subject><subject>hemodialysis fistula</subject><subject>randomized trial</subject><subject>renal failure</subject><issn>1744-9979</issn><issn>1744-9987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNqFkD1PwzAQQC0EoqUwsyGPLGnt2LFrtqjio6hAh4rVcpwLDUrqYidCZWLlb_JLaGnpipezTu_e8BA6p6RP129AJeeRUkPZp0wJcYC6-83h_i9VB52E8EpIHHPGjlGHCUGEGLIuehg_9qfpaIbTZ2yshRCwN4vc1eUH5Ljxpamu8L1ZmgW2bu58g13bWFdDwM3cu_Zljmn8_flVu0UzD6foqDBVgLPd7KHZzfVsdBdNnm7Ho3QSWS65iAxXnMecMihAMptlRgpFEmoYSJpleSaEIbaA2HBaGM4kxCyhYAQxKs6B9dDlVrv07q2F0Oi6DBaqyizAtUHHUlA1FAlJ1uhgi1rvQvBQ6KUva-NXmhK9Sag3kfQmmP5NuL642MnbrIZ8z_81WwPJFngvK1j959OzdLoV_wCC6Hsq</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Haruguchi, Hiroaki</creator><creator>Suemitsu, Kotaro</creator><creator>Isogai, Naoko</creator><creator>Murakami, Masaaki</creator><creator>Fujihara, Masahiko</creator><creator>Iwadoh, Kazuhiro</creator><creator>Menk, Jeremiah</creator><creator>Ookubo, Hiroko</creator><creator>Ogawa, Tomonari</creator><general>John Wiley & Sons Australia, Ltd</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7001-9220</orcidid><orcidid>https://orcid.org/0000-0001-5713-987X</orcidid><orcidid>https://orcid.org/0000-0002-2294-194X</orcidid><orcidid>https://orcid.org/0000-0002-4251-5315</orcidid><orcidid>https://orcid.org/0000-0002-5184-6335</orcidid><orcidid>https://orcid.org/0000-0001-5000-5203</orcidid><orcidid>https://orcid.org/0000-0003-1670-7740</orcidid><orcidid>https://orcid.org/0000-0003-3332-2527</orcidid></search><sort><creationdate>202308</creationdate><title>IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months</title><author>Haruguchi, Hiroaki ; Suemitsu, Kotaro ; Isogai, Naoko ; Murakami, Masaaki ; Fujihara, Masahiko ; Iwadoh, Kazuhiro ; Menk, Jeremiah ; Ookubo, Hiroko ; Ogawa, Tomonari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4746-a49442413efe73cbba769051a3e71bbdb66a0cfe2a41fa437e2351ea60a92de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>balloon angioplasty</topic><topic>dialysis access</topic><topic>drug‐coated balloon</topic><topic>hemodialysis fistula</topic><topic>randomized trial</topic><topic>renal failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haruguchi, Hiroaki</creatorcontrib><creatorcontrib>Suemitsu, Kotaro</creatorcontrib><creatorcontrib>Isogai, Naoko</creatorcontrib><creatorcontrib>Murakami, Masaaki</creatorcontrib><creatorcontrib>Fujihara, Masahiko</creatorcontrib><creatorcontrib>Iwadoh, Kazuhiro</creatorcontrib><creatorcontrib>Menk, Jeremiah</creatorcontrib><creatorcontrib>Ookubo, Hiroko</creatorcontrib><creatorcontrib>Ogawa, Tomonari</creatorcontrib><creatorcontrib>IN.PACT AV Access Investigators</creatorcontrib><creatorcontrib>the IN.PACT AV Access Investigators</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic apheresis and dialysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haruguchi, Hiroaki</au><au>Suemitsu, Kotaro</au><au>Isogai, Naoko</au><au>Murakami, Masaaki</au><au>Fujihara, Masahiko</au><au>Iwadoh, Kazuhiro</au><au>Menk, Jeremiah</au><au>Ookubo, Hiroko</au><au>Ogawa, Tomonari</au><aucorp>IN.PACT AV Access Investigators</aucorp><aucorp>the IN.PACT AV Access Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months</atitle><jtitle>Therapeutic apheresis and dialysis</jtitle><addtitle>Ther Apher Dial</addtitle><date>2023-08</date><risdate>2023</risdate><volume>27</volume><issue>4</issue><spage>682</spage><epage>693</epage><pages>682-693</pages><issn>1744-9979</issn><eissn>1744-9987</eissn><abstract>Purpose
There is a lack of adjudicated and prospectively randomized published outcomes on the use of drug‐coated balloons (DCB) to treat dysfunctional arteriovenous fistula in Asian patients. This post hoc subgroup analysis of 112 Japanese participants from the global IN.PACT AV Access trial reports outcomes through 12 months.
Materials and Methods
Participants were treated with DCB (n = 58) or standard non‐coated percutaneous transluminal angioplasty (PTA) balloons (n = 54). Outcomes included target lesion primary patency (TLPP), access circuit primary patency, and safety.
Results
Through 6 months, TLPP was 86.0% (49/57) in the DCB group and 49.1% (26/53) in the PTA group (p < 0.001). Through 12 months, TLPP was 67.3% (37/55) in the DCB group and 43.4% (23/53) in the PTA group (p = 0.013).
Conclusion
In this post hoc analysis of Japanese participants from the IN.PACT AV Access trial, participants treated with DCB had higher TLPP through 6 and 12 months compared with PTA.</abstract><cop>Kyoto, Japan</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>36606683</pmid><doi>10.1111/1744-9987.13966</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-7001-9220</orcidid><orcidid>https://orcid.org/0000-0001-5713-987X</orcidid><orcidid>https://orcid.org/0000-0002-2294-194X</orcidid><orcidid>https://orcid.org/0000-0002-4251-5315</orcidid><orcidid>https://orcid.org/0000-0002-5184-6335</orcidid><orcidid>https://orcid.org/0000-0001-5000-5203</orcidid><orcidid>https://orcid.org/0000-0003-1670-7740</orcidid><orcidid>https://orcid.org/0000-0003-3332-2527</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1744-9979 |
| ispartof | Therapeutic apheresis and dialysis, 2023-08, Vol.27 (4), p.682-693 |
| issn | 1744-9979 1744-9987 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2761986505 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | balloon angioplasty dialysis access drug‐coated balloon hemodialysis fistula randomized trial renal failure |
| title | IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T05%3A35%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IN.PACT%20AV%20access%20randomized%20trial:%20Japan%20cohort%20outcomes%20through%2012%E2%80%89months&rft.jtitle=Therapeutic%20apheresis%20and%20dialysis&rft.au=Haruguchi,%20Hiroaki&rft.aucorp=IN.PACT%20AV%20Access%20Investigators&rft.date=2023-08&rft.volume=27&rft.issue=4&rft.spage=682&rft.epage=693&rft.pages=682-693&rft.issn=1744-9979&rft.eissn=1744-9987&rft_id=info:doi/10.1111/1744-9987.13966&rft_dat=%3Cproquest_cross%3E2761986505%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2761986505&rft_id=info:pmid/36606683&rfr_iscdi=true |